According to the current analysis of Reports and Data, the global hyperhidrosis treatment market was valued at USD 1.27 Billion in 2019 and is expected to reach USD 2.10 Billion by the year 2027, at a CAGR of 6.0%. Hyperhidrosis is a severe disorder in which the patient faces excessive sweating issues which are independent of environmental conditions and thermoregulatory needs. There are two basic types of medical condition in this illness- primary focal and secondary generalized hyperhidrosis. Diaphoresis, which is a severe form of extreme, abnormal sweating is also known as secondary hyperhidrosis. The increasing awareness about the various types of treatment alternatives available to permanently cure in case of severe perspiration and to improve the quality of life in case of minor perspiration, is expected to bring traction to the hyperhidrosis treatment industry. Also there are updated reimbursement implications for hyperhidrosis expenditure in multiple regions. For instance, in U.S. recently in 2019, a reimbursement scheme code was released for operating procedures and medications, ICD-10-CM is the diagnosis code.
The condition of such excessive perspiring issues generally arises in either in the childhood itself or sometimes in the adolescence as well and can remain for many years. Majorly the cases of perspiration involves the areas of high sweat gland density such as armpits, hands, palms, feet and soles and in some rare cases it occurs on the face as well. There are various treatment options for healing this condition which can be adopted according to the severity level of the disease. It can be treated by medications such as antiperspirants, anticholinergics and botox injections as well. For excessive armpit perspiring, a product for permanent treatment was launched in 2016 called miraDry, for permanent removal of excessive sweating issues. However various measures have been suggested by doctors and specialists for removing perspiration and for improving the quality of life for such people. Less intake of alcohol is commonly suggested by doctors to slow down the onset of excessive sweating episodes. According to International Hyperhidrosis Society of U.S., proper clothing can give relief and comfort to the patients to a great extent. For example, Cool-jams performance sleep, is a clothing product manufactured especially for excessive sweating affected people. Summer Soles is a specially made sole for foot wears which reduces the sweating tendency to great extends.
North America has maximum increase in number of cases related to excessive sweating in the past few years, among major developed nations. The prevalence rate associated with hyperhidrosis in the U.S. was around 5% in 2017, where more than half of the cases registered were of axillary hyperhidrosis.
Furthermore, increased government and NGO initiatives, availability of research funds from private as well as public bodies, improvement in the reimbursement scenario for treatment and devices, and rising awareness about benefits of using available medications are among the key factors propelling the hyperhidrosis treatment market.
Further key findings from the report suggest:
- For primary focal hyperhidrosis treatment, there is only one FDA approved injection in the industry which is the botox injection by Allergan. It held the highest market share in the previous year’s numbers registered for this segment. Other rising players in the industry for botox medication includes Dysport, and Xeomin, which are currently sold off-labeled in the market.
- Various new treatment methods such as microwave therapy are providing impetus to the industry due to its effectiveness for removing excessive sweat problems permanently. miraDry launched by Miramar Labs is an effective solution for sweating disorders.
- Leading companies are into new product development for bringing up better products for the target illness treatment. For instance, Candela Corp. is engaged in development of a laser therapy for primary hyperhidrosis treatment. It is a laser treatment device especially made for axillary hyperhidrosis relief. However the response towards the device by patients is expected to be slow.
- The physiotherapy type segment of treatments is anticipated to grow gradually with the increasing awareness of physiotherapy techniques such as iontophoresis in the hyperhidrosis treatment market with an expected CAGR of 6.3% and estimated market value of USD 240.1 million in 2026.
- North America remains the key revenue generating geographical segment in hyperhidrosis treatment market. The geographical segment accounted for USD 388.7 million in 2018. Availability of research funds from public as well as private sources, availability of state-of-art technologies, presence of key market players in the region, favorable reimbursements scenarios for excessive sweating based diagnostics, rising focus on precision medicine, and rising awareness about presence of safer medicines, are among the key factors driving the market growth for Hyperhidrosis Treatment in this region
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Hyperhidrosis Treatment market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.
Leading companies operating in the market are:
Allergan (Ireland), Brickell Biotech, Inc. (U.S), Dermira, Inc. (U.S), GlaxoSmithKline plc (UK), Revance Therapeutics , Inc. (U.S), Ulthera, Inc. (U.S), Dr. August Wolff GmbH (Germany), TheraVida, Sientra Inc. (U.S)
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/2059
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Hyperhidrosis Treatment Market Segmentation:
Disease type Outlook (Revenue in Million USD; 2017–2027)
- Primary Focal Hyperhidrosis
- Palmar Hyperhidrosis
- Plantar Hyperhidrosis
- Others
Treatment Type Outlook (Revenue in Million USD; 2017–2027)
- Medications
- Physiotherapy
- Surgical Treatments
Distribution Channel (Revenue in Million USD; 2017–2027)
- Hospital Pharmacy
- Retail Pharmacy
- Online Prescription Stores
Geographic Segment Covered in the Report:
The Hyperhidrosis Treatment report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.
• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)
Key market aspects are illuminated in the report:
- Executive Summary: It covers a summary of the most vital studies, the Global Hyperhidrosis Treatment market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.
- Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global Hyperhidrosis Treatment market, the years measured, and the study points.
- Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.
- Manufacture by Region: This Global Hyperhidrosis Treatment report offers data on imports and exports, sales, production and key companies in all studied regional markets.
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Reverse Transcriptase Market @ https://www.reportsanddata.com/report-detail/reverse-transcriptase-market
Oxyclozanide Market @ https://www.reportsanddata.com/report-detail/oxyclozanide-market
Nerve Stimulators Market @ https://www.reportsanddata.com/report-detail/nerve-stimulators-market
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/report-detail/hyperhidrosis-treatment-market